Severe and fatal central nervous system toxicity after fludarabine, thiotepa and melphalan conditioning for allogeneic stem cell transplantation

Neurological complications (NC) are a known risk after allogeneic hematopoietic stem cell transplantation (allo-HSCT). In routine clinical care, we observed unexpected severe noninfectious central nervous system (CNS) events following conditioning with fludarabine, thiotepa and melphalan (Flu-Thio-Mel). To assess the potential association between NC and Flu-Thio-Mel conditioning, we conducted a systematic retrospective evaluation of the frequency, type, location and etiology of NC in adult patients who received αβTCR+/CD19+-depleted allo-HSCT. Only NC considered conditioningrelated, based on clinical and diagnostic findings, were included. Outcomes were compared between patients receiving Flu-Thio-Mel (N=55) and patients receiving fludarabine and busulfan (Flu-Bu; N=47) as conditioning regimen for allo-HSCT. Overall, NC were frequent in both cohorts (31% after Flu-Thio-Mel and 30% after Flu-Bu) and most often clinically mild. Peripheral neuropathy was the most common manifestation. In contrast, CNS toxicity was observed exclusively in the Flu-Thio-Mel cohort (n=7), presenting as fatal leukoencephalopathy (n=3, CTCAE grade 5), severe encephalomyelopathy (n=2, CTCAE grade 3-4), and myeloneuropathy (n=2, CTCAE grade 2). Older age, impaired renal function and higher fludarabine exposure may have increased susceptibility to Flu-Thio-Mel-associated CNS toxicity. The occurrence of severe CNS toxicity (CTCAE grade 3-5) in 9% of patients after Flu-Thio-Mel warrants caution and further evaluation of this conditioning regimen, particularly in vulnerable patients.

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-11-19
DOI
https://doi.org/10.3324/haematol.2026.301403
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Severe and fatal central nervous system toxicity after fludarabine, thiotepa and melphalan conditioning for allogeneic stem cell transplantation

Jan Willem Dankbaar, Maaike Dirks, Arief Lalmohamed, Sharon Berendsen et al.
Haematologica
Hematopoietic Stem Cell Transplantation
article

Severe and fatal central nervous system toxicity after fludarabine, thiotepa and melphalan conditioning for allogeneic stem cell transplantation

Jan Willem Dankbaar, Maaike Dirks, Arief Lalmohamed, Sharon Berendsen, Moniek A. de Witte, Lotte E. van der Wagen, Klaartje Nijssen, Pleun Schonewille, Jurgen Kuball, Laura Daenen, Bram Kottink, Aurelia de Vries Schultink, Viola Kraak, Yousra Van der Leest
article en

Abstract

Neurological complications (NC) are a known risk after allogeneic hematopoietic stem cell transplantation (allo-HSCT). In routine clinical care, we observed unexpected severe noninfectious central nervous system (CNS) events following conditioning with fludarabine, thiotepa and melphalan (Flu-Thio-Mel). To assess the potential association between NC and Flu-Thio-Mel conditioning, we conducted a systematic retrospective evaluation of the frequency, type, location and etiology of NC in adult patients who received αβTCR+/CD19+-depleted allo-HSCT. Only NC considered conditioningrelated, based on clinical and diagnostic findings, were included. Outcomes were compared between patients receiving Flu-Thio-Mel (N=55) and patients receiving fludarabine and busulfan (Flu-Bu; N=47) as conditioning regimen for allo-HSCT. Overall, NC were frequent in both cohorts (31% after Flu-Thio-Mel and 30% after Flu-Bu) and most often clinically mild. Peripheral neuropathy was the most common manifestation. In contrast, CNS toxicity was observed exclusively in the Flu-Thio-Mel cohort (n=7), presenting as fatal leukoencephalopathy (n=3, CTCAE grade 5), severe encephalomyelopathy (n=2, CTCAE grade 3-4), and myeloneuropathy (n=2, CTCAE grade 2). Older age, impaired renal function and higher fludarabine exposure may have increased susceptibility to Flu-Thio-Mel-associated CNS toxicity. The occurrence of severe CNS toxicity (CTCAE grade 3-5) in 9% of patients after Flu-Thio-Mel warrants caution and further evaluation of this conditioning regimen, particularly in vulnerable patients.

Haematologica
Utrecht University (NL), University Medical Center Utrecht (NL)
Hematopoietic Stem Cell Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon